CORRESP Filing
iBio, Inc.
Date: Feb. 5, 2026 · CIK: 0001420720 · Accession: 0001104659-26-011059
AI Filing Summary & Sentiment
File numbers found in text: 333-293085
Show Raw Text
CORRESP 1 filename1.htm February 5, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: iBio, Inc. Registration Statement on Form S-3 Filed January 30, 2026 File No: 333-293085 Dear Mr. Howes: iBio, Inc. (the " Registrant ") hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-293085) (the " Registration Statement "), be accelerated by the U.S. Securities and Exchange Commission (the " Commission ") to become effective on Monday, February 9, 2026 , at 5:00 p.m ., Eastern Time, or as soon as reasonably practicable thereafter. The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Leslie Marlow at (212) 885-5358 or Melissa Palat Murawsky at (215) 569-5732 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted. Very truly yours, IBIO, INC. By: /s/ Marc A. Banjak Name: Marc A. Banjak Title: Chief Legal Officer cc: Leslie Marlow, Blank Rome LLP Melissa Palat Murawsky, Blank Rome LLP